Video

How Bayer Is Still Learning About DCT Trials

Source: Clinical Leader

In a segment from Last Year's DCT Is Today's Clinical Trial, we hear insights from distinguished guests: Merissa Govender, Global Innovation Leader at Sanofi; Lindsay Kehoe, Senior Project Manager at Clinical Trials Transformation Initiative (CTTI); and Aneta Woroniecka-Osio, DCT Strategy Development Lead at Bayer.

Specifically in this clip, Woroniecka-Osio sheds light on Bayer's adoption of DCT methodologies, noting that three out of four DCT-related trials have been conducted in a hybrid fashion.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)